Fabien Vaudant is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director Global Program Lead at Fresenius Kabi since September 2017. Previously, Fabien held various leadership roles at the Healthcare Business of Merck from May 2011 to August 2017, including Director of Global Program Leader Biosimilars and Director of Global Product Team Leader for a kinase inhibitor in Oncology. Fabien's experience encompasses strategic managerial positions, project management, and cross-functional team leadership in oncology and biotechnology, with early roles at Merck Serono and EMD Pharmaceuticals. Fabien's academic background includes a Master's in Strategy and B2B Marketing from Ecole de Management de Lyon, a DESS in Biotechnology from Université Victor Segalen, and a Master's in Molecular and Cellular Biology from Université Claude Bernard.